|
| U.S. Brand
Names |
|
| Comhist®; Comhist®
LA |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Antihistamine/Decongestant Combination |

|
|
| Use |
|
|
Symptomatic relief of rhinitis and nasal congestion due to colds or
allergy |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Usual Dosage |
|
|
Oral: 1 capsule every 8-12 hours or 1-2 tablets 3
times/day |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
Use with caution since phenylephrine is a sympathomimetic amine which could
interact with epinephrine to cause a pressor response |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
Chlorpheniramine: Prolonged use will cause significant xerostomia
Phenylephrine: Up to 10% of patients could experience tachycardia,
palpitations, and dry mouth; use vasoconstrictor with caution
|

|
|
| Dosage Forms |
|
|
Capsule, sustained release (Comhist® LA):
Chlorpheniramine maleate 4 mg, phenylephrine hydrochloride 20 mg, and
phenyltoloxamine citrate 50 mg
Tablet (Comhist®): Chlorpheniramine maleate 2 mg,
phenylephrine hydrochloride 10 mg, and phenyltoloxamine citrate 25 mg
|

|
|
Copyright © 2007 Drugs Area
|